Quality-of-life analysis of pembrolizumab vs brentuximab vedotin for relapsed/refractory classical Hodgkin lymphoma
Titel:
Quality-of-life analysis of pembrolizumab vs brentuximab vedotin for relapsed/refractory classical Hodgkin lymphoma
Auteur:
Zinzani, Pier Luigi Ramchandren, Radhakrishnan Santoro, Armando Paszkiewicz-Kozik, Ewa Gasiorowski, Robin Johnson, Nathalie A. de Oliveira, Jose S.R. Buccheri, Valeria Perini, Guilherme Fleury Dickinson, Michael McDonald, Andrew Özcan, Muhit Sekiguchi, Naohiro Zhu, Ying Raut, Monika Saretsky, Todd L. Nahar, Akash Kuruvilla, John